{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T22:52:59Z","timestamp":1786747979805,"version":"build-2736575974"},"reference-count":41,"publisher":"American Chemical Society (ACS)","issue":"5","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["614739-A_HERO"],"award-info":[{"award-number":["614739-A_HERO"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ACS Infect. Dis."],"published-print":{"date-parts":[[2021,5,14]]},"DOI":"10.1021\/acsinfecdis.0c00435","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T22:02:12Z","timestamp":1601416932000},"page":"1069-1076","source":"Crossref","is-referenced-by-count":13,"title":["Characterization of Moxidectin against <i>Strongyloides ratti<\/i>: In Vitro and In Vivo Activity and Pharmacokinetics in the Rat Model"],"prefix":"10.1021","volume":"7","author":[{"given":"Valentin","family":"Buchter","sequence":"first","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002 Basel, Switzerland"},{"name":"University of Basel, Petersplatz 1, P.O. Box, CH-4001 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002 Basel, Switzerland"},{"name":"University of Basel, Petersplatz 1, P.O. Box, CH-4001 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"H\u00e4berli","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002 Basel, Switzerland"},{"name":"University of Basel, Petersplatz 1, P.O. Box, CH-4001 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0290-3521","authenticated-orcid":true,"given":"Jennifer","family":"Keiser","sequence":"additional","affiliation":[{"name":"Swiss Tropical and Public Health Institute, Socinstrasse 57, P.O. Box, CH-4002 Basel, Switzerland"},{"name":"University of Basel, Petersplatz 1, P.O. Box, CH-4001 Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"ref1\/cit1","unstructured":"WHO. Soil-transmitted helminth infections\n2020 [updated 2020-02-03. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/soil-transmitted-helminth-infections. Date accessed 2020-08-21."},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002288"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68653-4"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001603"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30519-5"},{"key":"ref6\/cit6","volume-title":"2030 targets for soil-transmitted helminthiases control programmes","author":"WHO","year":"2019"},{"key":"ref7\/cit7","unstructured":"WHO. African\nProgramme for Onchocerciasis\nControl (APOC) 2020. Available from: https:\/\/www.who.int\/apoc\/cdti\/ivermectin\/en\/. Date accessed 2020-08-21."},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5056314"},{"key":"ref9\/cit9","volume-title":"Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions - A Manual for Health Professionals and Programme Managers","author":"WHO","year":"2006"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-2-S2-S5"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix278"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.2012.01424.x"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7519(01)00174-6"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32844-1"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4017(94)00743-V"},{"issue":"2","key":"ref16\/cit16","first-page":"113","volume":"29","author":"Alvinerie M.","year":"1998","journal-title":"Vet Res."},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1021\/jf00038a028"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.572"},{"key":"ref19\/cit19","unstructured":"WHO. First\nnew treatment for river\nblindness approved by U.S. FDA in 20 years 2018 [updated 2018-06-18].\nAvailable from: https:\/\/www.who.int\/tdr\/news\/2018\/moxidectin-approved-as-treatment-for-river-blindness\/en\/. Date accessed 2020-08-24."},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003257456"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1053\/tvjl.2000.0521"},{"key":"ref22\/cit22","doi-asserted-by":"crossref","unstructured":"Hofmann, D., Sayasone, S., and Keiser, J. (2020) Development and validation of a LC-MS\/MS method for the quantification of the anthelmintic drug moxidectin in Mitra\u00ae, blood and plasma: Application to a pharmacokinetic study of adults infected with strongyloides in Laos. [Analytical method]. To be submitted.","DOI":"10.1016\/j.jchromb.2021.122556"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4017(01)00472-1"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2004.71.608"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000885"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-019-3476-x"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000136"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1007\/s004360100479"},{"key":"ref29\/cit29","unstructured":"FDA (2018) Bioanalytical Method Validation Guidance for Industry U.S. Food & Drug Administration"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(96)00423-1"},{"key":"ref31\/cit31","unstructured":"FDA (2018) Moxidectin\nprescribing\ninformation [2020-08-24]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210867lbl.pdf. Date accessed [2020-08-24]."},{"key":"ref32\/cit32","unstructured":"FDA (2017) Moxidectin non-clinical\nreport [2020-08-24]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2018\/210867Orig1s000PharmR.pdf. Date accessed [2020-08-21]."},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetpar.2018.12.016"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4017(97)00077-0"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1053\/tvjl.2002.0715"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02489-18"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1053\/rvsc.1998.0304"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2009.06.008"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00287-13"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2010.01.007"},{"key":"ref41\/cit41","unstructured":"R Core Team (2018) RFfSC.\nR: A Language and Environment for Statistical Computing [Available\nfrom: https:\/\/www.R-project.org\/. Date accessed 2020-08-21."}],"container-title":["ACS Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.0c00435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T03:40:48Z","timestamp":1682653248000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acsinfecdis.0c00435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5,14]]}},"alternative-id":["10.1021\/acsinfecdis.0c00435"],"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.0c00435","relation":{},"ISSN":["2373-8227","2373-8227"],"issn-type":[{"value":"2373-8227","type":"print"},{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}